Stanley-Laman Group’s NuVasive, Inc. NUVA Stock Holding History

Stanley-Laman Group’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,714	Closed	-$594K	–	297
2017 Q3	$594K	Buy	+10,714	New	+$709K	0.16%	160

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Stanley-Laman Group's NUVA Position: Q4 2017 in Review

Stanley-Laman Group sold out of NuVasive, Inc. (NUVA) in Q4 2017, closing a stake of 10,714 shares — an estimated $594K sold.

Stanley-Laman Group first reported a position in NUVA in Q3 2017 and held it in 1 quarter. The position peaked at $594K in Q3 2017. 269 funds tracked by Wall St. Rank hold NUVA as of Q4 2017.

Stanley-Laman Group reported no remaining NuVasive, Inc. position as of Q4 2017 after selling out during the quarter.
Stanley-Laman Group sold 10,714 NuVasive, Inc. shares in Q4 2017, an estimated $594K.
Stanley-Laman Group first reported a position in NuVasive, Inc. in Q3 2017 and held it in 1 quarter.
Stanley-Laman Group's NuVasive, Inc. position peaked at $594K in Q3 2017.
269 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2017.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.